national institutes of health | Scholarship for Nigerians and Africans

Research Grants by National Institutes of Health 2011, USA: Translation of Pluripotent Stem Cell Therapies for Blood Diseases

This FOA issued by the National Heart, Lung, and Blood Institute, National Institutes of Health, encourages Research Project Grant (R01) applications from institutions and organizations that propose collaborative, multidisciplinary, multi-Project Director/Principal Investigator research for the development of new technologies needed to utilize stem cells in future cell therapies to treat sickle cell disease and other blood disorders. This initiative focuses on two key areas that are impediments to further progress: (1) development of techniques to efficiently generate hematopoietic cells by either differentiation of human pluripotent stem cells (PSC) or by cellular reprogramming to yield sufficient numbers of GMP quality cells for clinical evaluation; and (2) development of protocols that enable the efficient engraftment of hematopoietic cells derived from pluripotent stem cells or derived by cellular reprogramming. Each multidisciplinary application will designate two or more Project Directors/Principal Investigators. This program will be implemented in collaboration with the ongoing NHLBI Progenitor Cell Biology Consortium and will add separate additional research projects. Extensive collaboration is expected between the existing Consortium Hubs, and the new group(s) are also expected to collaborate extensively with the Consortium Hubs.

Only the review criteria described below will be considered in the review process. As part of the NIH mission, all applications submitted to the NIH in support of biomedical and behavioral research are evaluated for scientific and technical merit through the NIH peer review system.

Scholarship Application Deadline:September 5, 2011

Further Scholarship Information and Application

Pfizer Medical & Academic Partnerships Program, USA: Health Care

Pfizer is proud to present our Medical & Academic Partnerships program, which improves patient care and increases the safe and effective use of our medicines. Since the inception of the Medical & Academic Partnerships program in 1984, Pfizer has funded more than 1000 proposals. This program is a reflection of Pfizer’s commitment to advancing research, innovation, and medical education in Schools of Medicine, Nursing, Osteopathic Medicine, Pharmacy and Public Health.


Pfizer’s Medical & Academic Partnerships program provides financial support for fellows in a wide range of therapeutic and public health areas.
* Fellowships provide career-building opportunities for therapeutic clinicians and academic researchers in basic, outcomes, and patient-oriented research that are vital to improving healthcare.
* Public-Private Partnerships with organizations such as the National Institutes of Health and the Centers for Disease Control and Prevention help develop future medical leaders and drive advances in patient care.

Selection Process
Each Medical & Academic Partnerships award area has an independent academic selection committee comprised of leaders in the program’s field. This committee selects the recipients of these nationally competitive awards and helps shape the structure and scope of future programs to maximize their impact.

Scholarship Application Deadline: February 11, 2011.

Further Scholarship Information and Application